Quarterly Activity Report and Appendix 4C for 31 Mar 2022
Imagion has released the Quarterly Activity Report and Appendix 4C for the period ending on 31 March 2022. The announcement highlights: MagSense® HER2 breast…
Imagion Biosystems April 2022 Investor Newsletter
We are pleased to provide our investors with our April 2022 Investor Newsletter. In this edition, our Chief Financial Officer, Geoff Hollis, gives a recap…
Employee Spotlight: Dan Inglese, Research Associate
Highlighting our dedicated employees who bring both their experience and passions to Imagion Biosystems: What experience do you bring prior to joining…
Welcome TJ Stalvey
We are pleased to welcome our latest Imagioneer to the Imagion Bio team! As we grow confidence in the development of our business, we are adding imperative…
MagSense® HER2 Breast Cancer First-in-human Study Progress Update
Imagion Biosystems Limited (ASX: IBX) is pleased to provide an update on the progress of its first-in-human study for the MagSense® HER2 breast cancer imaging…
Imagion Biosystems 2021 Full Year Results
Imagion Biosystems has released its Annual Report for the year ended 31 December 2021. See linked documents below. 2021 Clinical Highlights: Multiple…
Quarterly Activity Report and Appendix 4C for 31 December 2021
Imagion has released the Quarterly Activity Report and Appendix 4C for the period ending on 31 December 2021. The announcement highlights a recap of the…
Imagion Bio at The Edison Open House: Global Healthcare 2022
Our CEO, Bob Proulx, connected with the Edison Group during their Global Healthcare Open House to discuss in detail, the nanotechnology behind our bio-imaging…
Application for quotation of +securities
The document "Application for quotation of +securities" was lodged with ASX on 6th January, 2022. Please click to review the full announcement at ASX.
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
The document "Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001" was lodged with ASX on 6th January, 2022. Please click to review the full…